Ally Bridge Group (NY) LLC Q3 2025 Filing
Filed November 14, 2025
Portfolio Value
$164.2B
Holdings
22
Report Date
Q3 2025
Filing Type
13F-HR
All Holdings (22 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | SLNOSOLENO THERAPEUTICS INC | 552,483 | $37.3B | 22.74% | Call |
| 2 | REPLREPLIMUNE GROUP INC | 3,600,000 | $15.1B | 9.19% | Call |
| 3 | MDGLMADRIGAL PHARMACEUTICALS INC | 32,662 | $15.0B | 9.12% | |
| 4 | CMPSCOMPASS PATHWAYS PLC | 2,172,082 | $12.4B | 7.58% | Call |
| 5 | ATAIATAI BECKLEY NV | 2,287,005 | $12.1B | 7.37% | |
| 6 | ASNDASCENDIS PHARMA A/S - ADR | 51,080 | $10.2B | 6.18% | |
| 7 | LENZLENZ THERAPEUTICS INC | 175,363 | $8.2B | 4.97% | |
| 8 | TSHATAYSHA GENE THERAPIES INC | 1,898,112 | $6.2B | 3.78% | |
| 9 | AMLXAMYLYX PHARMACEUTICALS INC | 437,391 | $5.9B | 3.62% | |
| 10 | EPRXEUPRAXIA PHARMACEUTICALS INC | 915,000 | $5.4B | 3.29% | |
| 11 | PRAXPRAXIS PRECISION MEDICINES I | 100,000 | $5.3B | 3.23% | Call |
| 12 | MNPRMONOPAR THERAPEUTICS INC | 64,455 | $5.3B | 3.21% | |
| 13 | ARQTARCUTIS BIOTHERAPEUTICS INC | 233,220 | $4.4B | 2.68% | |
| 14 | BRD1EURMIND MEDICINE MINDMED INC | 361,444 | $4.3B | 2.60% | |
| 15 | TARSTARSUS PHARMACEUTICALS INC | 70,778 | $4.2B | 2.56% | |
| 16 | SLDBSOLID BIOSCIENCES INC | 549,182 | $3.4B | 2.06% | |
| 17 | PMNEURPROMIS NEUROSCIENCES INC | 6,233,497 | $2.6B | 1.61% | |
| 18 | AVTXAVALO THERAPEUTICS INC | 178,100 | $2.3B | 1.38% | |
| 19 | TECXTECTONIC THERAPEUTIC INC | 138,595 | $2.2B | 1.32% | |
| 20 | WHWKWHITEHAWK THERAPEUTICS INC | 817,939 | $1.6B | 0.95% | |
| 21 | MLTXMOONLAKE IMMUNOTHERAPEUTICS | 69,000 | $494.7M | 0.30% | Call |
| 22 | ATYRATYR PHARMA INC | 600,000 | $432.8M | 0.26% | Call |